Literature DB >> 20360165

Magnetic resonance spectroscopy evaluation in patients with neuromyelitis optica.

Jérôme de Seze1, Frédéric Blanc, Stéphane Kremer, Nicolas Collongues, Marie Fleury, Christophe Marcel, Izzie-Jacques Namer.   

Abstract

OBJECTIVE: Neuromyelitis optica (NMO) is an inflammatory disease associated with optic neuritis and myelitis. Although some studies have reported multiple sclerosis (MS)-like lesions in 10-30% of NMO patients, brain MRI is usually normal. Several studies have observed metabolic abnormalities on MR spectroscopy in MS, even in normal-appearing white matter (NAWM). To the authors' knowledge, MR spectroscopy has never been used to investigate NMO. The aim of this study was to evaluate metabolic abnormalities in the NAWM and normal-appearing grey matter (NAGM) of NMO patients.
METHODS: The authors evaluated 24 patients (17 women and seven men, with a mean age of 44.6 years). NMO was diagnosed according to revised criteria. All patients had a brain and spinal cord MR imaging including MR spectroscopy sequences in both NAWM and NAGM. Patients were compared with 12 healthy subjects.
RESULTS: NAA/creatinine ratios in NAWM (1.89 + or - 0.26 in NMO compared with 1.91 + or - 0.15 in control subjects) and NAGM (1.62 + or - 0.21 compared with 1.59 + or - 0.18) were normal, as were choline/creatinine ratios in NAWM (1.03 + or - 0.18 compared with 1.08 + or - 0.14) and NAGM (0.89 + or - 0.2 compared with 0.94 + or - 0.2). Myo-inositol values in NAWM were also normal (0.42 + or - 0.12 compared with 0.42 + or - 0.18).
CONCLUSION: Our results are clearly different from those found in MS, where NAA is frequently decreased and choline increased, even in NAWM. Our findings could have an impact on the differentiation between MS and NMO.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20360165     DOI: 10.1136/jnnp.2008.168070

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  12 in total

Review 1.  Brain MRI in neuromyelitis optica: what is its role?

Authors:  Wei Qiu; Allan G Kermode
Journal:  Curr Neurol Neurosci Rep       Date:  2011-12       Impact factor: 5.081

Review 2.  The current role of MRI in differentiating multiple sclerosis from its imaging mimics.

Authors:  Ruth Geraldes; Olga Ciccarelli; Frederik Barkhof; Nicola De Stefano; Christian Enzinger; Massimo Filippi; Monika Hofer; Friedemann Paul; Paolo Preziosa; Alex Rovira; Gabriele C DeLuca; Ludwig Kappos; Tarek Yousry; Franz Fazekas; Jette Frederiksen; Claudio Gasperini; Jaume Sastre-Garriga; Nikos Evangelou; Jacqueline Palace
Journal:  Nat Rev Neurol       Date:  2018-03-09       Impact factor: 42.937

3.  Brain parenchymal damage in neuromyelitis optica spectrum disorder - A multimodal MRI study.

Authors:  F Pache; H Zimmermann; C Finke; A Lacheta; S Papazoglou; J Kuchling; J Wuerfel; B Hamm; K Ruprecht; F Paul; A U Brandt; M Scheel
Journal:  Eur Radiol       Date:  2016-03-24       Impact factor: 5.315

Review 4.  Use of Advanced Magnetic Resonance Imaging Techniques in Neuromyelitis Optica Spectrum Disorder.

Authors:  Stephane Kremer; Felix Renard; Sophie Achard; Marco A Lana-Peixoto; Jacqueline Palace; Nasrin Asgari; Eric C Klawiter; Silvia N Tenembaum; Brenda Banwell; Benjamin M Greenberg; Jeffrey L Bennett; Michael Levy; Pablo Villoslada; Albert Saiz; Kazuo Fujihara; Koon Ho Chan; Sven Schippling; Friedemann Paul; Ho Jin Kim; Jerome de Seze; Jens T Wuerfel; Philippe Cabre; Romain Marignier; Thomas Tedder; Danielle van Pelt; Simon Broadley; Tanuja Chitnis; Dean Wingerchuk; Lekha Pandit; Maria Isabel Leite; Metha Apiwattanakul; Ingo Kleiter; Naraporn Prayoonwiwat; May Han; Kerstin Hellwig; Katja van Herle; Gareth John; D Craig Hooper; Ichiro Nakashima; Douglas Sato; Michael R Yeaman; Emmanuelle Waubant; Scott Zamvil; Olaf Stüve; Orhan Aktas; Terry J Smith; Anu Jacob; Kevin O'Connor
Journal:  JAMA Neurol       Date:  2015-07       Impact factor: 18.302

Review 5.  Conventional and advanced imaging in neuromyelitis optica.

Authors:  Y Barnett; I J Sutton; M Ghadiri; L Masters; R Zivadinov; M H Barnett
Journal:  AJNR Am J Neuroradiol       Date:  2013-06-13       Impact factor: 3.825

6.  White matter atrophy and cognitive dysfunctions in neuromyelitis optica.

Authors:  Frederic Blanc; Vincent Noblet; Barbara Jung; François Rousseau; Felix Renard; Bertrand Bourre; Nadine Longato; Nadjette Cremel; Laure Di Bitonto; Catherine Kleitz; Nicolas Collongues; Jack Foucher; Stephane Kremer; Jean-Paul Armspach; Jerome de Seze
Journal:  PLoS One       Date:  2012-04-03       Impact factor: 3.240

7.  Quantitative 7T MRI does not detect occult brain damage in neuromyelitis optica.

Authors:  Baptiste Pasquier; Nadja Borisow; Ludwig Rasche; Judith Bellmann-Strobl; Klemens Ruprecht; Thoralf Niendorf; Tobias J Derfuss; Jens Wuerfel; Friedemann Paul; Tim Sinnecker
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2019-03-07

8.  Reduced Myelin Signal in Normal-appearing White Matter in Neuromyelitis Optica Measured by 7T Magnetic Resonance Imaging.

Authors:  I-Jun Chou; Radu Tanasescu; Olivier E Mougin; Penny A Gowland; Christopher R Tench; William P Whitehouse; Bruno Gran; Esmaeil Nikfekr; Basil Sharrack; Gordon Mazibrada; Cris S Constantinescu
Journal:  Sci Rep       Date:  2019-10-07       Impact factor: 4.379

9.  Brain abnormalities in neuromyelitis optica spectrum disorder.

Authors:  Woojun Kim; Su-Hyun Kim; So-Young Huh; Ho Jin Kim
Journal:  Mult Scler Int       Date:  2012-12-03

10.  Imaging Surrogates of Disease Activity in Neuromyelitis Optica Allow Distinction from Multiple Sclerosis.

Authors:  Lucy Matthews; Shannon Kolind; Alix Brazier; Maria Isabel Leite; Jonathan Brooks; Anthony Traboulsee; Mark Jenkinson; Heidi Johansen-Berg; Jacqueline Palace
Journal:  PLoS One       Date:  2015-09-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.